APP Pharmaceuticals, Inc. (Nasdaq:APPX), a leading manufacturer of multi-source and branded injectable pharmaceutical products, today announced it will release its 2008 second quarter financial results after the market closes on Thursday, July 31, 2008. The Company also said that senior management will host an investor conference call on Friday, August 1, 2008 at 7:00 a.m. PT/10:00 a.m. ET to review the company’s financial results.

The conference call will be available to interested parties through a live audio webcast at www.APPpharma.com and www.thomsonone.com. The call will be archived and accessible at both sites for six months.

About APP Pharmaceuticals

APP is a fully-integrated pharmaceutical company that develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. The Company offers one of the most comprehensive product portfolios used in hospitals, long-term care facilities, alternate care sites and clinics within North America and manufactures a comprehensive range of dosage formulations.

Investors and Media Inquiries:
APP Pharmaceuticals, Inc.
Maili Bergman, Director, Investor Relations, 310-405-7522
or
PondelWilkinson Inc.
Robert Jaffe, 310-279-5969